Výsledky vyhledávání

Data from Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

Purpose:Triple-negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Antibodies targeting programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD-L1) have entered the therapeutic landscape in TNBC, but only a minor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e551cda28c1fd25f0ef23972aa309b8
https://doi.org/10.1158/1078-0432.c.6531311.v1

Zobrazit plný text záznamu

Figure S5 from Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

Figure S5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a596ca06ec554d854aa13d403d5a24
https://doi.org/10.1158/1078-0432.22484048

Zobrazit plný text záznamu

Table S1 from Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

Table S1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ca7169c9f34582371ebebd076f3eb7
https://doi.org/10.1158/1078-0432.22484039

Zobrazit plný text záznamu

Supplementary methods from Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

Supplementary methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b225ca75afa3d921ee14dfdf27630e8
https://doi.org/10.1158/1078-0432.22484042

Zobrazit plný text záznamu

Intratumoral plasmid IL-12 expands CD8(+) T cells and induces a CXCR3 gene signature in triple-negative breast tumors that sensitizes patients to anti-PD-1 therapy

Publikováno v: Clin Cancer Res

Purpose: Triple-negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Antibodies targeting programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD-L1) have entered the therapeutic landscape in TNBC, but only a mino

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c48e8953fa4ba2b471eaae121c3944b
https://europepmc.org/articles/PMC8102331/

Zobrazit plný text záznamu

Akademický článek

A systematic revision of the large-scaled Marcusenius with description of a new species from Cameroon (Teleostei; Osteoglossomorpha; Mormyridae).

Autor: Boden, G., Teugels, G.G., Hopkins, C.D.

Publikováno v: Journal of Natural History; Nov1997, Vol. 31 Issue 11, p1645-1682, 38p, 11 Diagrams, 8 Charts, 4 Maps

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání